Skip to main content
. 2020 Jul 3;12(7):1781. doi: 10.3390/cancers12071781

Figure 1.

Figure 1

High expression of EZH2 and CXCR4 is associated with the poor prognosis of glioblastoma (GBM) patients. (A) EZH2 and CXCR4 mRNA levels are significantly higher in GBM tumor tissues than normal tissues (tumor samples, n = 163; normal samples, n = 207). * p < 0.05: significantly different from normal tissues. (B) Both high EZH2 or CXCR4 levels correspond with the reduced disease-free survival of GBM patients based on data obtained from Gene Expression Profiling Interactive Analysis (GEPIA).